Buys | $154,036 | 5 | 56 |
Sells | $275,137 | 4 | 44 |
Alland Leila | director | 1 | $51,799 | 0 | $0 | $51,799 |
Seshadri Vishwas | Chief Executive Officer | 1 | $32,000 | 0 | $0 | $32,000 |
O'Malley Brendan M. | SVP, General Counsel | 1 | $27,864 | 0 | $0 | $27,864 |
Charles Faith L. | director | 1 | $24,764 | 0 | $0 | $24,764 |
Vazzano Joseph Walter | Chief Financial Officer | 1 | $17,609 | 0 | $0 | $17,609 |
Silverstein Christine Berni | director | 0 | $0 | 1 | $116,453 | $-116,453 |
Alvino Mark | director | 0 | $0 | 3 | $158,684 | $-158,684 |
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease; ABO-401 for the treatment of cystic fibrosis; and ABO-50X for the treatment of genetic eye …
Over the last 12 months, insiders at Abeona Therapeutics Inc. have bought $154,036 and sold $275,137 worth of Abeona Therapeutics Inc. stock.
On average, over the past 5 years, insiders at Abeona Therapeutics Inc. have bought $134,796 and sold $1.08M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Alland Leila (director) — $51,799. Seshadri Vishwas (Chief Executive Officer) — $32,000. O'Malley Brendan M. (SVP, General Counsel) — $27,864.
The last purchase of 11,000 shares for transaction amount of $51,799 was made by Alland Leila (director) on 2024‑05‑16.
2025-01-29 | Sale | Alvino Mark | director | 4,000 0.0092% | $5.38 | $21,520 | +0.92% | |
2025-01-21 | Sale | Alvino Mark | director | 4,000 0.0091% | $5.10 | $20,400 | +5.01% | |
2024-06-18 | Sale | Silverstein Christine Berni | director | 25,821 0.0635% | $4.51 | $116,453 | +23.68% | |
2024-06-18 | Sale | Alvino Mark | director | 25,890 0.0637% | $4.51 | $116,764 | +23.68% | |
2024-05-16 | Alland Leila | director | 11,000 0.0286% | $4.71 | $51,799 | +20.76% | ||
2024-04-26 | Charles Faith L. | director | 7,550 0.0265% | $3.28 | $24,764 | +68.71% | ||
2024-04-25 | Seshadri Vishwas | Chief Executive Officer | 10,000 0.0343% | $3.20 | $32,000 | +72.41% | ||
2024-04-25 | Vazzano Joseph Walter | Chief Financial Officer | 5,608 0.0189% | $3.14 | $17,609 | +72.41% | ||
2024-04-25 | O'Malley Brendan M. | SVP, General Counsel | 8,600 0.0299% | $3.24 | $27,864 | +72.41% | ||
2024-02-06 | Seshadri Vishwas | Chief Executive Officer | 20,000 0.0784% | $4.39 | $87,800 | +32.33% | ||
2024-01-17 | Sale | Alvino Mark | director | 7,084 0.0285% | $5.11 | $36,199 | +9.53% | |
2023-09-27 | Sale | Amoroso Michael | director | 5,508 0.022% | $3.91 | $21,542 | +21.97% | |
2023-09-27 | Sale | Silverstein Christine Berni | director | 6,330 0.0252% | $3.91 | $24,721 | +21.97% | |
2023-09-27 | Sale | Alland Leila | director | 7,246 0.0288% | $3.90 | $28,270 | +21.97% | |
2023-09-27 | Sale | Charles Faith L. | director | 8,330 0.0417% | $4.91 | $40,924 | +21.97% | |
2023-09-27 | Sale | Alvino Mark | director | 6,316 0.0252% | $3.91 | $24,724 | +21.97% | |
2023-09-27 | Seshadri Vishwas | Chief Executive Officer | 20,000 0.083% | $4.07 | $81,400 | +21.97% | ||
2023-09-20 | Sale | Amoroso Michael | director | 327 0.0014% | $3.90 | $1,275 | +25.79% | |
2023-09-19 | Vazzano Joseph Walter | Chief Financial Officer | 3,000 0.0122% | $3.82 | $11,458 | +26.12% | ||
2023-09-18 | O'Malley Brendan M. | SVP, General Counsel | 3,000 0.0125% | $3.80 | $11,400 | +30.25% |
Seshadri Vishwas | Chief Executive Officer | 538260 1.2382% | $2.85M | 3 | 0 | +27.15% |
Vazzano Joseph Walter | Chief Financial Officer | 233868 0.538% | $1.24M | 3 | 0 | +3.41% |
O'Malley Brendan M. | SVP, General Counsel | 188718 0.4341% | $998,318.22 | 4 | 5 | +5.36% |
Alland Leila | director | 82857 0.1906% | $438,313.53 | 1 | 1 | |
Charles Faith L. | director | 78323 0.1802% | $414,328.67 | 1 | 1 |
$21,574,635 | 88 | 2.81% | $217.93M | |
$7,150,333 | 87 | -8.28% | $207.01M | |
$69,130,029 | 69 | 25.63% | $240.78M | |
$11,468,215 | 44 | 17.78% | $246.73M | |
$48,218,096 | 42 | 0.89% | $204.72M |
Increased Positions | 31 | +54.39% | 3M | +9.82% |
Decreased Positions | 18 | -31.58% | 941,288 | -3.27% |
New Positions | 15 | New | 572,147 | New |
Sold Out Positions | 4 | Sold Out | 63,983 | Sold Out |
Total Postitions | 70 | +22.81% | 31M | +6.55% |
Adage Capital Partners Gp, L.L.C. | $20,448.00 | 9.07% | 3.9M | +652,366 | +20.07% | 2024-12-31 |
Suvretta Capital Management, Llc | $19,312.00 | 8.57% | 3.69M | 0 | 0% | 2024-12-31 |
Nantahala Capital Management, Llc | $18,493.00 | 8.21% | 3.53M | +96,577 | +2.81% | 2024-12-31 |
Millennium Management Llc | $11,094.00 | 4.92% | 2.12M | -184,459 | -8.01% | 2024-12-31 |
Western Standard Llc | $10,922.00 | 4.85% | 2.08M | +386,321 | +22.75% | 2024-12-31 |
Vanguard Group Inc | $10,302.00 | 4.57% | 1.97M | -41,603 | -2.07% | 2024-12-31 |
Vivo Capital, Llc | $9,656.00 | 4.29% | 1.84M | 0 | 0% | 2024-12-31 |
Rosalind Advisors, Inc. | $9,460.00 | 4.2% | 1.81M | -26,610 | -1.45% | 2024-12-31 |
Laurion Capital Management Lp | $6,847.00 | 3.04% | 1.31M | 0 | 0% | 2024-12-31 |
683 Capital Management, Llc | $4,149.00 | 1.84% | 791,845 | +116,845 | +17.31% | 2024-12-31 |